-
Berberine, RAGE/POMC, and Metabolic Control
2026-09-03
A 2026 pre-proof study identifies RAGE as a central nervous system target of berberine within Tianhuang Formula and links RAGE/POMC signaling to hypothalamic neuronal apoptosis, autophagy, and glucolipid metabolism. Its integrated computational, cellular, and mouse-model design offers a mechanistic framework for studying neuronal regulation of metabolic disease while leaving questions about causality, dosing, and clinical translation unresolved.
-
Toremifene Citrate: Applied Research Workflows
2026-09-03
Build reproducible estrogen receptor assays with Toremifene Citrate, from DMSO stock preparation through MCF-7 proliferation and pathway readouts. The workflow emphasizes concentration selection, vehicle controls, receptor-context validation, and translational interpretation for breast cancer research.
-
(+)-Bicuculline: Practical Protocol Guide
2026-09-02
(+)-Bicuculline is a neuroscience research tool for probing GABAA receptor-mediated inhibition, related GABAergic signaling pathway responses, and synaptic NMDA receptor signaling modulation. It is intended only for controlled scientific research and should not be used for diagnostic, therapeutic, or other medical purposes.
-
Nanoparticle Uptake in Human Corneal Cells
2026-09-02
This 2024 study shows that nanoparticle size and surface chemistry influence how PLGA nanoparticles interact with human corneal epithelial cells, with energy-dependent endocytosis as the principal uptake mechanism. Its combined cell–mucosal model and inhibitor analysis identify macropinocytosis and caveolae-mediated uptake as important pathways, providing a practical framework for designing topical ocular delivery systems.
-
Indole-3-pyruvic Acid: Pathways and Research Use
2026-09-01
Indole-3-pyruvic acid (IPA) is a tryptophan-derived metabolite that links plant indole-3-acetic acid biosynthesis, fungal auxin production, and mammalian AhR research. Its reported pathway effects are organism-specific, so experimental interpretation requires matched controls, prompt solution use, and separation of preclinical findings from clinical evidence.
-
Dual Luciferase Reporter Gene System: Practical Guide
2026-09-01
Learn how to use the Dual Luciferase Reporter Gene System to normalize promoter and enhancer measurements in mammalian cells, including a practical workflow inspired by ZNF263–ULK1 research. The guide combines assay design, high-throughput implementation, data interpretation, and troubleshooting for more reliable gene expression regulation studies.
-
Candida albicans EVs Repress Hyphal Development
2026-08-31
This 2026 study identifies a concentration-dependent role for Candida albicans extracellular vesicles (EVs): accumulated EVs suppress hyphal development by increasing the transcriptional repressor NRG1 through SKO1-associated regulation. The same pathway reduced fungal burden and improved survival in a mouse candidemia model, providing mechanistic evidence that fungal EVs can restrain, rather than simply promote, pathogenic behavior.
-
Dibutyryl-cAMP, sodium salt in Neuronal Assays
2026-08-31
Dibutyryl-cAMP, sodium salt provides a cell-permeable way to manipulate cAMP-dependent signaling while investigators track neuronal conversion, PKA responses, and phenotype-specific gene regulation. This practical guide connects DBcAMP sodium salt with the PTBP2–RBFOX3 findings in fibroblast-to-neuron research, emphasizing controls, dose-finding, and troubleshooting rather than treating the analog as a substitute for reprogramming factors.
-
Dextromethorphan Hydrobromide: Translational Leverage
2026-08-30
Dextromethorphan hydrobromide offers a useful framework for connecting NMDA receptor antagonism, ion-channel modulation, and neuroprotection research with more rigorous translational decision-making. This article outlines how to validate excitotoxicity inhibition, design cerebral ischemia model workflows, and distinguish mechanistic promise from clinical readiness.
-
FCCP: Mitochondrial Uncoupling for HIF Studies
2026-08-29
FCCP, also called carbonyl cyanide p-trifluoromethoxyphenylhydrazone, is a lipophilic mitochondrial uncoupler that dissipates the proton gradient driving ATP synthesis. Its controlled energetic stress supports mitochondrial biology research, HIF pathway experiments, and metabolic regulation studies, but it does not establish direct inhibition of every HIF or immunometabolic target.
-
Panobinostat Drives Calcineurin Degradation in Myeloma
2026-08-28
The 2016 JCI Insight study identified the calcineurin catalytic subunit PPP3CA as a clinically relevant vulnerability in multiple myeloma and showed that panobinostat promotes its degradation. Its combination with FK506 or bortezomib strengthened antimyeloma activity in experimental models, providing a mechanistic framework for addressing treatment resistance and osteolytic disease.
-
GLI2 Drives Immune Evasion Through WNT and Prostaglandins
2026-08-28
DeVito et al. identify GLI2 as a mechanistic link between mesenchymal transformation, tumor immune suppression, and resistance to anti-PD-1 therapy. The study shows that GLI2 coordinates WNT ligand production and prostaglandin signaling to reshape myeloid and lymphoid compartments, providing a rationale for pathway-specific combination strategies.
-
Covalent SARS-CoV-2 Mpro Binders from HCV Drugs
2026-08-27
The 2022 Scientific Reports study used X-ray crystallography, binding data, and molecular docking to show that three clinically approved hepatitis C drugs and two drug-like compounds covalently engage the SARS-CoV-2 main protease at catalytic Cys145. Its principal contribution is structural evidence supporting drug repositioning screening and providing a mechanism-informed starting point for antiviral lead optimization, while stopping short of demonstrating cellular or clinical efficacy.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-08-27
This Advanced Science study uses single-cell transcriptomic and B-cell receptor profiling to show that glucose-poor, hypoxic primary central nervous system lymphoma adapts through SLC2A5-mediated fructose metabolism. Genetic and pharmacologic disruption of SLC2A5 suppressed lymphoma growth in functional models, identifying a metabolic vulnerability shared by malignant cells and tumor-supportive macrophages.
-
Salinomycin Workflows for HCC Research
2026-08-26
Build reproducible hepatocellular carcinoma assays around Salinomycin’s ion-transport, apoptosis, calcium, and Wnt/β-catenin effects. This practical guide connects dose-response design with orthogonal validation, controls for ionophore-specific artifacts, and translates animal-to-cell toxicity insights without overstating clinical readiness.